Back to News
Market Impact: 0.1
Transcenta Appoints Former Sino Biopharmaceutical CFO Jennie Ma
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Transcenta Holding Ltd. (6628.HK), a biopharmaceutical company, announced Jennie Ma’s appointment as chief financial officer on Monday. The report provided no further details about the appointment or its expected financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Crushed tech stocks bounce — plus, new doctor survey keeps us positive on Lilly
- Capital One, General Motors are among the stocks reporting this week with momentum. Here are the others
- Netflix film boss Dan Lin out as streaming giant continues to overhaul top ranks
- Merck KGaA to acquire Silence Therapeutics for $1.3 billion
- Disc Medicine surges 38% after bitopertin clears Phase 3 trial endpoints
- Silence Therapeutics jumps 59% on Merck takeover
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data
- Best AI Stock Research Tools for Professional Investors